Overview
Norway is among the highest scoring in terms of Policy Context. This is due to a comprehensive asthma strategy, severe asthma guidelines, and Norway’s reporting to severe asthma registries. Limited alignment of national guidelines with international best practices and comparatively modest tobacco control laws limit Norway’s ability to score higher in this category. In terms of Access and Care Coverage, Norway ranks close to average. While Norway shows relatively low unmet needs and high levels of access to biologics-based treatment, specialist care, and diagnostics such as inflammatory phenotyping, improvement could be made in access to other treatments, digital therapeutics, and FeNO-based diagnosis. Norway has among the lowest Disease Burden scores, which is attributable to one of the highest estimated societal costs of asthma and the number of DALYs attributable to asthma. Having some of the lowest rates of adult tobacco use improves Norway’s score in this category.
How does Norway perform in each category?
Provides further insights into how Norway scores across each Index category
Norway takeaways
Data from the Severe Asthma Index revealed the following key insights about severe asthma care in Norway
A strong asthma strategy, severe asthma guidelines and severe asthma registries boost Norway’s score in Policy Context
Norway has a high level of access to biologics-based treatment, specialist care and inflammatory-phenotyping-based diagnostics
Norway has a high estimated societal cost and number of DALYs attributable to asthma
Compare Norway to other countries
Select different countries to see how they scored across each of the 5 categories and overall